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1  | INTRODUC TION
Aging is a complex, multifarious process characterized by changes 
such as stem cell exhaustion, mitochondrial dysfunction, impaired 
immune function, reduced autophagy, epigenetic alterations, accu‐
mulation of somatic and mitochondrial DNA mutations, aberrant in‐
tercellular communication, loss of telomeres, altered nutrient sensing, 
and impaired protein homeostasis (Lopez‐Otin, Blasco, Partridge, 
Serrano, & Kroemer, 2013; Singh, Demmitt, Nath, & Brunet, 2019). 
A large portion of our current, limited understanding of what causes 
aging comes from lifespan studies in short‐lived model organisms. 
By identifying genetic, pharmacological, and dietary interventions 
that both extend and reduce lifespan, we have gleaned that specific 
molecular mechanisms—like the target of rapamycin (TOR), insulin/
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Abstract
An emerging body of data suggests that lipid metabolism has an important role to 
play in the aging process. Indeed, a plethora of dietary, pharmacological, genetic, and 
surgical lipid‐related interventions extend lifespan in nematodes, fruit flies, mice, and 
rats. For example, the impairment of genes involved in ceramide and sphingolipid 
synthesis extends lifespan in both worms and flies. The overexpression of fatty acid 
amide hydrolase or lysosomal lipase prolongs life in Caenorhabditis elegans, while the 
overexpression of diacylglycerol lipase enhances longevity in both C. elegans and 
Drosophila melanogaster. The surgical removal of adipose tissue extends lifespan in 
rats, and increased expression of apolipoprotein D enhances survival in both flies and 
mice. Mouse lifespan can be additionally extended by the genetic deletion of diacyl‐
glycerol acyltransferase 1, treatment with the steroid 17‐α‐estradiol, or a ketogenic 
diet. Moreover, deletion of the phospholipase A2 receptor improves various health‐
span parameters in a progeria mouse model. Genome‐wide association studies have 
found several lipid‐related variants to be associated with human aging. For example, 
the epsilon 2 and epsilon 4 alleles of apolipoprotein E are associated with extreme 
longevity and late‐onset neurodegenerative disease, respectively. In humans, blood 
triglyceride levels tend to increase, while blood lysophosphatidylcholine levels tend 
to decrease with age. Specific sphingolipid and phospholipid blood profiles have also 
been shown to change with age and are associated with exceptional human longevity. 
These data suggest that lipid‐related interventions may improve human healthspan 
and that blood lipids likely represent a rich source of human aging biomarkers.
K E Y W O R D S
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insulin‐like growth factor (IGF), and adenosine monophosphate‐acti‐
vated protein kinase (AMPK) signaling pathways—play integral roles 
in regulating aging (Singh et al., 2019). The identification of aging 
biomarkers that change over time has concomitantly helped us to 
understand what mechanisms underlie aging. For example, nicotin‐
amide adenine dinucleotide (NAD+) concentrations decrease during 
aging and high‐fat diets as well as increase in response to caloric 
restriction, exercise, and fasting (Verdin, 2015). Moreover, NAD+ 
supplementation extends lifespan in mice (Zhang et al., 2016) as 
well as in yeast and worms (Verdin, 2015). This biomarker data (i.e., 
that NAD+ levels decrease with age) preceded the lifespan data and 
paved the way for studies exploring the effects of NAD+ repletion 
on aging.
Due to the sheer amount of time and cost required to validate a 
study in humans, the bulk of our aging and lifespan data come from 
shorter‐lived yeast, worms, flies, and rodents. With the exception of 
research showing that caloric restriction improves health and sur‐
vival in rhesus monkeys (Mattison et al., 2017), little aging work has 
been done in longer‐lived organisms. The bulk of our understanding 
regarding aging comes from genetic experiments in model organisms 
(Singh et al., 2019), and we do not yet know how similar or dissim‐
ilar human aging is. For example, genome‐wide association studies 
searching for longevity‐related variants have found a lack of associ‐
ation with many genes known to extend lifespan in simpler animals 
(de Magalhaes, 2014). This is likely due to major biological differ‐
ences between these organisms and humans as well as the limited 
genetic diversity of laboratory animal strains. As such, it is probable 
that a large portion of aging interventions proven in the laboratory 
will not yield significant clinical effects in humans (de Magalhaes, 
2014). Therapies that are evolutionarily conserved between differ‐
ent model organisms are, however, more likely to have a therapeu‐
tic effect in Homo sapiens. Caloric restriction, for example, extends 
lifespan or improves health in every organism tested—including rad‐
ically disparate animals such as mosquitoes (Joy, Arik, Corby‐Harris, 
Johnson, & Riehle, 2010) and humans (Kraus et al., 2019; Most, Tosti, 
Redman, & Fontana, 2017).
Rather than screen every lifespan‐extending intervention in 
humans to better understand how human aging works, another 
approach would be to utilize aging biomarkers. Biomarkers that 
strongly correlate with aging, lifespan, and healthspan can teach us 
about which processes are involved in human aging. They can also 
help us understand, independent of an individual's chronological 
age, how old a patient is biologically. Clinically, this could be used as 
an important health assessor. For example, Fleischer et al recently 
generated and analyzed a large dataset of genome‐wide RNA‐seq 
profiles of human dermal fibroblasts (Fleischer et al., 2018). These 
fibroblasts were derived from 133 people aged one to 94 years old. 
By developing an ensemble machine learning method, they were 
able to estimate an individual's age to a median error of four years. 
Testing in ten progeria patients revealed that this transcriptomic 
approach was capable of predicting accelerated aging (Fleischer et 
al., 2018). These data are impactful as they suggest that, with suffi‐
cient biomarker knowledge, patient senescence could be accurately 
measured by looking at objective, computer‐analyzed parameters. In 
the clinic, this would enable precision medicine by giving doctors the 
ability to make patient‐specific decisions based on their aging state. 
Put differently, a patient's true biological age could be accurately as‐
certained instead of making assumptions based on their chronologi‐
cal age. Currently, generalized recommendations are provided given 
average outcomes associated with different age groups. Robust bio‐
markers would also allow us to rapidly test the efficacy of rejuvena‐
tive interventions in humans (Mahmoudi, Xu, & Brunet, 2019).
Myriad types of aging biomarkers exist. They can take the form 
of physiological and clinical data such as white blood cell count, 
absolute monocyte count, blood pressure, body mass index, resting 
heart rate, forced expiratory volume, gait speed, and grip strength 
(Burkle et al., 2015; Sebastiani et al., 2017; Xia, Chen, McDermott, 
& Han, 2017). As an example of how useful one of these biomarker 
parameters can be, grip strength is highly predictive of mortality, 
morbidity, and future disability (Leong et al., 2015). Biomarkers can 
also manifest as analyzed genomic, epigenetic, transcriptomic, and 
proteomic data. The epigenetic marker DNAm PhenoAge, which 
is comprised of DNA methylation information from 513 different 
CpGs, was shown to strongly correlate with age in every tissue 
tested and to be predictive of all‐cause mortality as well as the 
age‐related diseases cancer and Alzheimer's disease (Levine et al., 
2018). By performing transcriptomic analyses, this marker was also 
associated with an increased activation of pro‐inflammatory path‐
ways as well as a decreased activation of DNA damage response 
genes (Levine et al., 2018). Efforts are currently underway to initi‐
ate a clinical trial that will utilize DNA methylation information to 
assess the efficacy of various antiaging interventions (Mitteldorf, 
2019). Biomarkers can additionally manifest as molecules such as 
carbohydrates, apolipoproteins, glycoproteins, hormones, cyto‐
kines, and lipids (Burkle et al., 2015; Sebastiani et al., 2017; Xia 
et al., 2017). Interleukin‐6, for instance, is a pro‐inflammatory cy‐
tokine and glycoprotein that increases in concentration with age 
(Maggio, Guralnik, Longo, & Ferrucci, 2006). This age‐related in‐
crease in interleukin‐6 fits into our current understanding that the 
immune system gets progressively dysregulated with age and that 
unhealthy inflammation contributes to senescence. The upreg‐
ulation of the interferon response pathway, for example, occurs 
during aging in multiple tissues from mice as well as in other verte‐
brate species such as rats, African turquoise killifish, and humans 
(Benayoun et al., 2019).
Ideally, a robust and practical biomarker would be one that incurs 
a low monetary cost and can be measured safely, repeatedly, and 
easily. Blood draws are especially appealing because they are inex‐
pensive, simple, low risk, and can be taken as needed throughout 
a patient's lifetime. While several biomarker studies have focused 
on protein‐based markers, the advancement of metabolomic tech‐
niques has made it feasible to look closely into a large array of me‐
tabolites. Metabolomic lipids and lipid‐related proteins represent a 
large, rich source of potential biomarkers that are easily measured 
in the blood. Compounds in lipid metabolism can take many forms, 
such as phospholipids, triglycerides, waxes, steroids, and fatty acids. 
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They also play diverse physiological roles, such as forming cell mem‐
branes and lipid rafts (Pike, 2003) as well as exerting powerful cell 
signaling effects (Sunshine & Iruela‐Arispe, 2017). Lipids are perhaps 
the most well‐known for the paramount roles they play in both the 
storage and mobilization of energy.
Although lipids have been traditionally treated as detrimen‐
tal and as simply associated with age‐related diseases, numerous 
studies have shown that lipid metabolism potently regulates aging 
and lifespan. Jové et al, for example, assessed the plasma lipidomic 
profiles of 11 different mammalian species with longevities varying 
from 3.5 to 120 years (Jove et al., 2013). They found that a lipid‐
omic profile could accurately predict an animal's lifespan and that, 
in particular, plasma long‐chain free fatty acids, peroxidizability 
index, and lipid peroxidation‐derived product content are inversely 
correlated with longevity (Jove et al., 2013). Similarly, Jobson et 
al scanned the genomes of 25 different species and reported that 
genes involved in lipid composition had undergone increased se‐
lective pressure in longer‐lived animals (Jobson, Nabholz, & Galtier, 
2010). Evidence from animals with extreme longevity also links 
lipid metabolism to aging. The ocean quahog clam Arctica islandica, 
an exceptionally long‐lived animal that can survive for more than 
500 years, exhibits a unique resistance to lipid peroxidation in mi‐
tochondrial membranes (Munro & Blier, 2012). The bowhead whale, 
another complex animal with extreme longevity that can live longer 
than 200 years, has lens membranes that are especially enriched 
with phospholipids. This unique enrichment is thought to at least 
partially underlie its uncanny resistance to the age‐related lens dis‐
ease of cataracts (Borchman, Stimmelmayr, & George, 2017). Naked 
mole rats, which enjoy remarkably long lifespans and healthspans 
for rodents, have a unique membrane phospholipid composition 
that has been theorized to contribute to their exceptional longevity 
(Mitchell, Buffenstein, & Hulbert, 2007). The importance of lipids in 
lifespan is further confirmed by the ability of lipid‐related interven‐
tions to enhance longevity in model organisms (Huang, Withers, & 
Dickson, 2014).
The goal of this review was to assess the potential of lipids or 
lipid‐related proteins to function as biomarkers of aging and to affect 
aging. To do this, we highlight how alterations in lipid metabolism can 
impact lifespan and age‐related disease. We discuss how these lipid‐
related interventions are distinct from those made by altering ca‐
nonical aging pathways and also highlight lipid‐associated signatures 
that correlate with extreme human longevity. Based on the existing 
data, we believe that lipids are a promising source of human aging 
biomarkers and that, clinically, they may be able to effectively de‐
termine a patient's biological age. We also believe that lipid‐related 
interventions represent a promising clinical strategy for improving 
human healthspan and ameliorating age‐related disease. Lastly, we 
propose aspects of lipid metabolism that could be clinically targeted 
to elongate the period of healthy life in humans. The ability of lipid‐
specific interventions to elongate both lifespan and healthspan in 
animal models demonstrates that, rather than being simply associ‐
ated with age‐related disease, lipid metabolism is a direct and potent 
regulator of aging.
2  | LIFESPAN E X TENSION VIA LIPID ‐
REL ATED INTERVENTIONS
One of the most effective ways to understand aging is to assess 
what interventions can modify lifespan. Different dietary, genetic, 
pharmacological, and surgical lipid‐related interventions have been 
shown capable of extending lifespan in model organisms such as 
worms (Tables 1 and 2), flies (Table 3), and rodents (Table 4). Although 
several lipid‐related therapies can boost longevity in yeast (Huang et 
al., 2014), we focus on aging studies in multicellular animals in this re‐
view. In this section, we limit our discussion to specific interventions 
that prolong longevity. In the subsequent section, we delve into 
associated mechanisms as well as observed trends between these 
life extension studies. Mentioned lipid synthesis pathways that are 
relevant to aging are visually summarized in Figure 1. The specifi‐
cally highlighted pathways are triglyceride synthesis (Ahmadian, 
Duncan, Jaworski, Sarkadi‐Nagy, & Sul, 2007; Shi & Cheng, 2009), 
sphingolipid synthesis (Gault, Obeid, & Hannun, 2010), fatty acid 
synthesis (Jump, 2011; Wakil, Stoops, & Joshi, 1983), and phospho‐
lipid synthesis (Vance, 2015; Figure 1). We have additionally created 
a table that briefly summarizes the primary function of each geneti‐
cally targeted lipid‐related protein implicated in lifespan regulation 
(Table 5).
2.1 | Nematodes
Different lipid‐related nongenetic (Table 1) and genetic (Table 2) 
interventions are capable of extending lifespan in Caenorhabditis 
elegans, including the supplementation with fatty acids. In re‐
sponse to fasting, O'Rourke, Kuballa, Xavier, and Ruvkun (2013) 
found that expression of lysosomal lipase lipl‐4 was induced, 
which in turn led to an enrichment of ω‐6 polyunsaturated fatty 
acids (PUFAs). Direct supplementation of the ω‐6 PUFAs arachi‐
donic acid and di‐homo‐γ‐linoleic acid in culture media promoted 
starvation resistance and extended animal lifespan. Inactivation 
of autophagy reversed this increase in lifespan, suggesting that 
autophagy underlies ω‐6 PUFA‐induced life extension (O'Rourke 
et al., 2013). Similarly, PUFA treatment with α‐linolenic acid can 
increase lifespan in a dose‐dependent manner. Oxidized α‐lino‐
lenic acid generates oxylipins, and the oxylipin 9S‐hydroperoxy‐
10E,12Z,15Z‐octadecatrienoic acid further increases longevity 
in α‐linolenic acid‐treated worms (Qi et al., 2017). Feeding with 
10‐hydroxy‐2‐decenoic acid, a fatty acid component of honeybee 
royal jelly, similarly increases lifespan (Honda et al., 2011). This 
fatty acid additionally confers oxidative and thermal stress toler‐
ance (Honda et al., 2015). Dietary supplementation with the mono‐
unsaturated fatty acids (MUFAs) oleic, palmitoleic, or cis‐vaccenic 
acid is also sufficient to increase lifespan. In addition, the accumu‐
lation of MUFAs underlies the life extension observed in worms 
with a deficiency in H3K4me3 methyltransferase, an important 
epigenetic enzyme (Han et al., 2017). The administration of fish 
oil containing the PUFAs eicosapentaenoic acid and docosahex‐
aenoic acid has also been reported to enhance longevity, though 
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too much fish oil had the effect of shortening lifespan (Sugawara, 
Honma, Ito, Kijima, & Tsuduki, 2013).
Other studies have reported nematode life extension in response 
to treatments with specific, nonfatty acid substances (Table 1). The 
plant lignan matairesinol, which acts as an adiponectin receptor ag‐
onist, was documented to extend mean lifespan by 25% in C. elegans 
(Su & Wink, 2015). Sesamin, which can inhibit delta 5 desaturase 
(Shimizu et al., 1991), is yet another lignan that has been reported to 
boost longevity (Nakatani et al., 2018). The compound α‐lipoic acid 
has been reported to regulate lipid metabolism via the deacetylase 
sirtuin 1 (Chen, Kang, Wang, & Lee, 2012). α‐lipoic acid, which is de‐
rived from the fatty acid octanoic acid (Solmonson & DeBerardinis, 
2018), increases thermal stress resistance and elongates life in 
C. elegans (Benedetti et al., 2008). It additionally attenuates H2O2 
levels and improves chemotaxis (Brown, Evans, & Luo, 2006). The 
histone deacetylase inhibitor and ketone body β‐hydroxybutyr‐
ate extend mean lifespan by 20% and increase thermotolerance in 
C. elegans. Relevant to the age‐related neurodegenerative diseases 
Alzheimer's disease and Parkinson's disease, treatment with this ke‐
tone body additionally decreases α‐synuclein aggregation and delays 
amyloid‐β toxicity (Edwards et al., 2014). Nematodes treated with 
phosphatidylcholine showed an analogous protection against am‐
yloid‐β toxicity. They additionally displayed longer lifespans under 
conditions of oxidative stress (Kim, Kim, Park, & Park, 2019).
Nematode lifespan can also be elongated via RNAi knock‐
down (Table 2). The yolk lipoprotein VIT/vitellogenin is capable 
TA B L E  1   Lipid‐related nongenetic interventions that extend lifespan in Caenorhabditis elegans
Intervention % Lifespan increase Relevant observations Reference
Administration of α‐lipoic acid 24.2 Attenuated hydrogen peroxide levels
Enhanced chemotaxis in older worms
Brown et al. (2006)
Administration of α‐lipoic acid 21 Conferred thermal stress resistance Benedetti et al. 
(2008)
Feeding with the royal jelly fatty acid 10‐
hydroxy‐2‐decenoic acid
12 Life extension was independent of the insulin sign‐
aling transcription factor DAF‐16
Honda et al. (2011)
Dietary supplementation with ω‐6 polyun‐
saturated fatty acids (arachidonic acid or 
di‐homo‐γ‐linoleic acid)
15.7 for arachidonic 
acid
17.3 for di‐homo‐γ‐lin‐
oleic acid
Inactivation of autophagy reverses the life exten‐
sion effect
Fasting induces the expression of the lysosomal 
lipase lipl‐4, which leads to an enrichment of ω‐6 
polyunsaturated fatty acids
O'Rourke et al. 
(2013)
Administration of fish oil containing 
eicosapentaenoic acid and docosahexae‐
noic acid
9.6 Large amounts of fish oil shortened lifespan
Fish oil increased lipid peroxide levels in a dose‐
dependent manner
Sugawara et al. 
(2013)
Administration of ketone body 
ß‐hydroxybutyrate
~20 Increased thermotolerance
Decreased α‐synuclein aggregation and delayed 
amyloid‐β toxicity
Life was not extended in a genetic model of dietary 
restriction
Edwards et al. 
(2014)
Supplementation with oleoylethanolamide 15.4 Constitutive expression of the lysosomal li‐
pase LIPL‐4 increased the abundance of 
oleoylethanolamide
Folick et al. (2015)
Supplementation with the lignan 
matairesinol
25 Tested lignans upregulated the expression of 
DAF‐16 and JNK‐1
Su and Wink (2015)
Dietary supplementation with monoun‐
saturated fatty acids (oleic, palmitoleic, or 
cis‐vaccenic acid)
20.98 for oleic acid
18.98 for palmitoleic 
acid
8.67 for cis‐vaccenic 
acid
Monounsaturated fatty acid accumulation is 
required for lifespan extension in H3K4me3 meth‐
yltransferase‐deficient worms
Han et al. (2017)
Dietary supplementation with α‐linolenic 
acid
~30 Life extension required the transcription factors 
NHR‐49/PPARα and SKN‐1/Nrf2
Additional treatment with the oxylipin 9(S)‐HpOTrE 
further increases lifespan
Qi et al. (2017)
Supplementation with the lignan sesamin 9.5 Life extension occurs via the SIRT1, TOR, and 
AMPK signaling pathways
Nakatani et al. 
(2018)
Treatment with phosphatidylcholine 28.8 Extended life under conditions of oxidative stress
Reduced fertility
Delayed decline in age‐related motility
Accumulation of DAF‐16 in the nucleus
Protection against amyloid‐β toxicity
Kim et al. (2019)
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of transporting cholesterol to oocytes. Gene silencing of various 
VIT genes (vit‐1/2, vit‐3, vit‐4, and vit‐5) boosts longevity, induces 
lysosomal lipolysis and autophagy, and increases neutral lipid 
accumulation (Seah et al., 2016). These data corroborate a prior 
report from the Cynthia Kenyon Laboratory, which found that 
RNAi knockdown against either vit‐2 or vit‐5 enhances longevity 
(Murphy et al., 2003). Using RNAi to inhibit elongation of fatty 
acid protein 1 (elo‐1), elongation of fatty acid protein 2 (elo‐2), or 
TA B L E  2   Lipid‐related genetic interventions that extend lifespan in Caenorhabditis elegans
Intervention % Lifespan increase Relevant observations Reference
RNAi against the yolk lipoprotein VIT/
vitellogenin (vit‐2 or vit‐5)
21–24.4 for vit‐2
9.7–21.5 for vit‐5
Downregulated in daf‐2	(−)	worms	and	
upregulated in daf‐16	(−)	worms
Murphy et al. (2003)
RNAi knockdown of the ceramide 
synthase gene hyl‐1
14–31 Neither deletion nor overexpression of 
hyl‐1 resulted in life extension
Tedesco et al. (2008)
Constitutive expression of the lysoso‐
mal lipase LIPL‐4
24 Long‐lived worms are lean
Lipid hydrolysis is induced via decreased 
insulin signaling
Wang et al. (2008)
RNAi knockdown of elongation of fatty 
acid protein 1 (elo‐1), elongation of 
fatty acid protein 2 (elo‐2), or the fatty 
acid desaturase fat‐4
11 for elo‐1
8 for elo‐2
15 for elo‐1 and elo‐2
25 for fat‐4
Knockdown of both elongases yielded 
a greater lifespan effect than either 
elongase alone
Depletion of fat‐4 produced the most 
significant life extension
Gene knockdown was accompanied by 
increased resistance to oxidative stress
Shmookler Reis et 
al. (2011)
Overexpression of fatty acid amide 
hydrolase faah‐1
9.1–60 Reduced levels of N‐acylethanolamines
Resistance to thermal stress
Life extension required the Foxa tran‐
scription factor PHA‐4
N‐acylethanolamine supplementation 
suppressed life extension
Lucanic et al. (2011)
Inactivation of acid sphingomyelinase‐3 
(asm‐3)
19 (RNAi knockdown)
14 (mutant worms)
Promotes dauer arrest
Life extension depend on the functions 
of daf‐18/PTEN and daf‐16/FOXO
Inactivation of age‐1/PI 3‐kinase further 
extends lifespan
Kim and Sun (2012)
Functional loss of the ceramide syn‐
thase genes hyl‐1 and lagr‐1
21.4 Knockdown of the autophagy‐associated 
gene ATG‐12 abolished the longevity 
effect
Increased number of autophagosomes
Reduced feeding and reproduction
Increased heat resistance
Mosbech et al. 
(2013)
Small interfering RNAs and pharma‐
cological inhibitors directed against 
glucosylceramide synthase, serine 
palmitoyltransferase, dihydrocera‐
mide desaturase, or neutral/acidic 
ceramidase
40 for glucosylceramide 
synthase
33 for serine 
palmitoyltransferase
40 for dihydroceramide 
desaturase
40 for neutral/acidic ceramidase
Slowed development rate
Worms fed a yolk diet rich in sphingolip‐
ids exhibited a reduced lifespan
Silencing of neutral sphingomyelinase 
shortened lifespan and accelerated 
development
Cutler et al. (2014)
Overexpression of diacylglycerol lipase 12–13 Diacylglycerol lipase mutants exhibit a 
shortened lifespan
Strains with less lipase activity show 
reduced resistance to oxidative stress
Lin et al. (2014)
RNAi against the yolk lipoprotein VIT/
vitellogenin (vit‐1/2, vit‐3, vit‐4, and 
vit‐5)
16–40 Induced autophagy and lysosomal 
lipolysis
Lifespan is reduced by VIT 
overexpression
Required the nuclear hormone receptors 
NHR‐49 and NHR‐80
Seah et al. (2016)
Overexpression of fat‐7 in the intestine 14.96–17.55 Increased fat accumulation
Supplementation with oleic acid did not 
further extend lifespan in these trans‐
genic worms
Han et al. (2017)
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the fatty acid desaturase fat‐4 can also extend nematode lifes‐
pan as well as increase resistance to oxidative stress. Elongase 
enzymes are responsible for extending carbon chains, while de‐
saturase enzymes work to create a carbon–carbon double bond 
by removing two hydrogen atoms from a fatty acid (Shmookler 
Reis et al., 2011). RNA interference against the ceramide synthase 
gene hyl‐1 is another route to life extension (Tedesco, Jiang, Wang, 
Jazwinski, & Johnson, 2008). Separate, relevant work has shown 
that hyl‐1 mutants are more resistant to anoxia than normal ani‐
mals (Menuz et al., 2009). Using small interfering RNAs against the 
sphingolipid synthesis enzymes glucosylceramide synthase, ser‐
ine palmitoyltransferase, dihydroceramide desaturase, and neu‐
tral/acidic ceramidase extends lifespan and slows development. 
Genetically modified serine palmitoyltransferase 1 (sptl‐1) mutant 
TA B L E  3   Lipid‐related interventions that extend fruit fly or mosquito lifespan
Species Intervention % Lifespan increase Relevant observations Reference
Drosophila bipectinata Feeding with various concentra‐
tions of the lipophilic butylated 
hydroxytoluene
19.04 for males
26.08 for females
Decreased rate of lipid 
peroxidation
Sharma and 
Wadhwa (1983)
Drosophila melanogaster Treatment with α‐lipoic acid 12 for females
4 for males
DJ651‐driven tetanus toxin 
(DTT) flies treated with α‐
lipoic acid exhibited increased 
survival times
Bauer et al. (2004)
D. melanogaster Overexpression of GLaz, the fly 
homolog of apolipoprotein D
29 Enhanced resistance to 
hypoxia
Superior walking and climbing 
posthyperoxia
Increased starvation resistance
Walker et al. (2006)
D. melanogaster Overexpression of human apoli‐
poprotein D
40–41 Enhanced protection against 
hyperoxia, dietary paraquat, 
and heat stress
Reduced age‐associated lipid 
peroxide accumulation
Muffat et al. (2008)
D. melanogaster Inactivation of Drosophila alkaline 
ceramidase (Dacer) via inser‐
tional mutagenesis
54.4 for females
48.3 for males
Increased anti‐oxidative stress 
capacity
Lengthened preadult develop‐
ment time
Elevated levels of ceramides
Yang et al. (2010)
D. melanogaster Overexpression of the fatty‐
acid‐β‐oxidation‐related genes 
fatty acid‐binding protein or dode‐
cenoyl‐CoA delta‐isomerase
81.3 for fatty acid‐
binding protein
31.3 for dode‐
cenoyl‐CoA 
delta‐isomerase
Enhanced tolerance to oxida‐
tive stress and starvation
Activation of dFOXO signal
Lee et al. (2012)
D. melanogaster Adult fat body overexpression of 
the histone deacetylase Sir2
~13 Transcriptional profiles suggest 
a role for Sir2 in regulating 
lipid droplet biology
Hoffmann et al. 
(2013)
D. melanogaster RNAi double knockdown of LDL 
receptor‐related protein 1 and 
LDL receptor‐related protein 2
Not reported 
(lifespan curves 
are shown only for 
females)
Larval growth is slowed and 
pupariation is delayed
AKT is less phosphorylated
Decrease in the number of 
lipoprotein‐positive neurons
Brankatschk et al. 
(2014)
D. melanogaster Overexpression of diacylglycerol 
lipase or knockdown of diacylg‐
lycerol kinase
72 Diacylglycerol lipase mutants 
exhibit a shortened lifespan 
and a reduced tolerance to 
oxidative stress
Lin et al. (2014)
Anopheles stephensi and 
Aedes aegypti
Transgenic overexpression of a 
myristoylated and active form of 
Akt in the fat body
14–47 for A. aegypti
15–45 for 
A. stephensi
Activation of the downstream 
signaling molecules forkhead 
box O and p70 S6 kinase
Increased expression of the fat 
body vitellogenin
Arik et al. (2015)
D. melanogaster Restricting dietary yeast during 
development
Up to 145 Suppression of toxic lipids 
underlies life extension
Toxic lipids can shorten male 
and female lifespan
Stefana et al. (2017)
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worms also lived longer. Conversely, a sphingolipid‐rich egg yolk 
diet accelerated development and shortened lifespan. Fatty acid 
chain desaturation and elongation in many sphingolipid species 
also increased during development and aging (Cutler, Thompson, 
Camandola, Mack, & Mattson, 2014). Further cementing a role for 
ceramides and worm aging, RNAi knockdown against acid sphin‐
gomyelinase‐3 (ASM‐3), an enzyme that produces ceramide by 
hydrolyzing sphingomyelin, extends animal lifespan. Genetically 
inactivating asm‐3 by introducing a mutation also extended life, 
though it did so to a reduced degree compared with RNAi‐treated 
worms (Kim & Sun, 2012).
Several studies have found that genetically modifying lipid 
genes enhance longevity (Table 2). In response to dietary restric‐
tion, there is a reduction in the number of N‐acylethanolamines, 
which are lipid‐derived signaling molecules. Inducing an N‐acy‐
lethanolamine deficiency via transgenic overexpression of fatty 
TA B L E  4   Lipid‐related interventions that extend rodent lifespan
Species Intervention % Lifespan increase Relevant observations Reference
Mus musculus Adipose‐specific insulin 
receptor knockout mice
18 Reduced fat mass and protection against age‐
related obesity
Bluher et al. 
(2003)
M. musculus Overexpression of human 
apolipoprotein D
41.6 or 27.5, depend‐
ing on the dose of 
paraquat
Increases survival under oxidative stress
Prevents the rise of brain lipid peroxides pos‐
toxidant treatment
Ganfornina et al. 
(2008)
Rattus 
norvegicus 
domesticus
Surgical removal of vis‐
ceral fat
Not reported (esti‐
mated to be ~20% of 
the longevity effect 
induced by caloric 
restriction)
Reduced incidence of severe renal disease
Similar rates of tumor incidence
Muzumdar et al. 
(2008)
M. musculus Mice with additional cop‐
ies of Pten, an inhibitor 
of the insulin signaling 
pathway
16 in males
9 in females
Lower cancer incidence
Increased energy expenditure, reduced adipos‐
ity, and hyperactive brown adipose tissue
Protection from insulin resistance and steatosis
Ortega‐Molina et 
al. (2012)
M. musculus Deficiency of the triglyc‐
eride synthesis enzyme 
acyl‐CoA:diacylglycerol 
acyltransferase 1
25 Female mice enjoyed protection from age‐re‐
lated increases in tissue triglycerides, white 
adipose tissue inflammation, and body fat
Middle‐aged mice displayed reduced fecundity 
and decreased levels of circulating insulin 
growth factor 1
Streeper et al. 
(2012)
M. musculus Knockout of the ubiqui‐
tin‐like gene FAT10
20 Higher metabolic rate, markedly reduced adipos‐
ity, and the preferential use of fat as fuel
Decreased triglyceride content
Enhanced insulin sensitivity
Canaan et al. 
(2014)
M. musculus Treatment with the 
steroid 17‐α‐estradiol 
(4.8 mg/kg)
12 in males Median, but not maximum, lifespan was in‐
creased. Female lifespan was unaffected
Harrison et al. 
(2014)
M. musculus Treatment with the 
steroid 17‐α‐estradiol 
(14.4 mg/kg)
19 in males Both median and maximal lifespan were in‐
creased. Female lifespan was unaffected
Strong et al. 
(2016)
M. musculus Feeding mice an isocaloric 
ketogenic diet (89% kcal 
from fat)
13.6 in males Improved motor function and memory in aged 
mice
Preservation of muscle mass
Reduced tumor incidence
Tissue‐dependent regulation of mTORC1 
signaling
Roberts et al. 
(2017)
M. musculus Knockdown of the phos‐
pholipase A2 receptor 
Pla2r1 in a mouse model 
of progeria
No statistically signifi‐
cant difference in sur‐
vival compared with 
controls, although 
maximum lifespan was 
increased in mice lack‐
ing Pla2r1
Improved grip strength
Increased bone mineral content
Reduced number of rib fractures
Decreased trabecular separation
Griveau et al. 
(2018)
M. musculus Adipose tissue‐specific 
overexpression of nicoti‐
namide phosphoribosyl‐
transferase
13.4 in females Aged transgenic mice display improvements in 
wheel running activity, sleep quality, glucose 
tolerance, glucose‐stimulated insulin secretion, 
and photoreceptor function
Yoshida et al. 
(2019)
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acid amide hydrolase, an enzyme that degrades N‐acylethanol‐
amines and other fatty acid amides, is sufficient to extend C. el‐
egans lifespan and increase thermal stress resistance. Transgenic 
worms with extra copies of this hydrolase had reduced levels of 
palmitoleoyl ethanolamide, linoleoyl ethanolamide, eicosapen‐
taenoyl ethanolamide, and arachidonoyl ethanolamide (Lucanic 
et al., 2011). Nematode longevity can also be increased via con‐
stitutive expression of the lysosomal lipase LIPL‐4, which is an 
enzyme that hydrolyzes fats such as cholesterol and triglycerides. 
These transgenic worms were lean and had fewer lipid droplets as 
well as decreased fat storage (Wang, O'Rourke, & Ruvkun, 2008). 
Subsequent work found that the constitutive expression of the 
lysosomal lipase LIPL‐4 increased the abundance of lipid oleoy‐
lethanolamide. This lipid promotes longevity and binds directly 
to the proteins LBP‐8 and NHR‐80 (Folick et al., 2015). Lipolysis 
mediated by LIPL‐4 was also found to work interdependently 
with autophagy to prolong lifespan in C. elegans (Lapierre, Gelino, 
Melendez, & Hansen, 2011; Lapierre, Melendez, & Hansen, 2012). 
Overexpression of the distinct lipid hydrolase diacylglycerol li‐
pase is another route to life extension and additionally promotes 
resistance to oxidative stress (Lin et al., 2014). Functional loss of 
the ceramide synthase genes hyl‐1 and lagr‐1 via genetic deletion 
also extends nematode lifespan. This aging effect is abrogated 
if the autophagy‐associated gene ATG‐12 is knocked down, and 
in worms lacking hyl‐1 and lagr‐1, an increased number of auto‐
phagosomes are observed. These nematodes additionally display 
increased heat resistance as well as reduced feeding and repro‐
duction (Mosbech et al., 2013). This work corroborates the pre‐
viously mentioned data, which reported that RNA interference 
against hyl‐1 prolongs life (Tedesco et al., 2008). Intestinal over‐
expression of the fatty acid desaturase enzyme FAT‐7 is another 
path to life extension in C. elegans. In addition to living longer, 
these transgenic worms accumulated more fat compared with 
controls (Han et al., 2017).
F I G U R E  1   Various aging‐relevant lipid synthesis pathways. The biosynthesis pathways for triglycerides (two different pathways), 
sphingolipids, fatty acids, and phospholipids are visually summarized. CK, choline kinase; CPT, CDP‐choline:1,2‐diacylglycerol 
cholinephosphotransferase; CT, CTP‐phosphocholine cytidylyltransferase; EK, ethanolamine kinase; EPT, CDP‐ethanolamine:1,2‐
diacylglycerol ethanolaminephosphotransferase; ET, CTP‐phosphoethanolamine cytidylyltransferase; MUFA, monounsaturated fatty acid; 
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PEMT, phosphatidylethanolamine methyltransferase; PS, phosphatidylserine; PSD, 
phosphatidylserine decarboxylase; PSS‐1, phosphatidylserine synthase‐1; PSS‐2, phosphatidylserine synthase‐2; PUFA, polyunsaturated 
fatty acid
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2.2 | Fruit flies
Lipids also impact lifespan in fruit flies (Table 3) and life extension 
can be induced by several different types of interventions, includ‐
ing dietary changes. Restricting dietary yeast during development in 
Drosophila melanogaster can more than double median lifespan, and 
the degree of life extension depends on the adult diet posteclosion. 
Larvae that were fed a low‐yeast diet and that were subsequently fed 
a low‐yeast diet, a high‐yeast diet, or a low‐yeast, high‐glucose diet 
as adults showed median lifespan increases of 20%–30%, 70%–90%, 
and up to 145%, respectively. An important mechanism underlying 
this life extension is the suppression of toxic lipids dubbed autotox‐
ins. These toxic lipids are shed into the environment and can shorten 
both male and female Drosophila lifespan (Stefana et al., 2017). In 
contrast to the negative effects of autotoxins, dietary supplemen‐
tation with various concentrations of the lipophilic compound and 
antioxidant butylated hydroxytoluene can increase both median and 
maximum lifespans in Drosophila bipectinata. Using the thiobarbituric 
acid test, it was also shown that flies fed butylated hydroxytoluene 
exhibited a decreased rate of lipid peroxidation compared with con‐
trols (Sharma & Wadhwa, 1983). The compound α‐lipoic acid, which 
was previously reported to prolong life in worms (Benedetti et al., 
2008; Brown et al., 2006), also extends life in D. melanogaster and 
does so in both females and males (Bauer, Goupil, Garber, & Helfand, 
2004).
Separate experiments have shown that gene inactivation via 
RNAi knockdown or insertional mutagenesis can boost longevity in 
Drosophila (Table 3). Glial‐specific double RNAi knockdown against 
the low‐density lipoprotein (LDL), receptor‐related protein 1 (LRP‐1), 
and the LDL receptor‐related protein 2 (LRP‐2) extends lifespan. In 
addition, larval growth is slowed and pupariation is delayed. These 
receptors were expressed in glial cells and responsible for moving 
lipoprotein across the blood–brain barrier. Knockdown against these 
receptors approximately halved the numbers of neurons positive for 
lipoprotein (Brankatschk, Dunst, Nemetschke, & Eaton, 2014). Both 
LRP‐1 and LRP‐2 are part of the low‐density lipoprotein receptor 
family, which is comprised of endocytic, cell‐membrane receptors 
that facilitate the lysosomal degradation of various extracellular li‐
gands (Spuch, Ortolano, & Navarro, 2012). Inactivation of Drosophila 
alkaline ceramidase, or Dacer, via insertional mutagenesis, is suf‐
ficient to extend lifespan and boost anti‐oxidative stress capacity. 
This life extension comes with a reproductive trade‐off where pre‐
adult development time is lengthened. Inactivation of Dacer also in‐
creased the level of most ceramide species containing either C14SPH 
or C16SPH (Yang et al., 2010).
Gene overexpression is another route to life extension in fruit 
flies (Table 3). Overexpression of diacylglycerol lipase or knockdown 
of diacylglycerol kinase elongates lifespan and enhances resistance 
to oxidative stress. Conversely, diacylglycerol lipase mutants experi‐
ence shorter lifespans and a reduced oxidative stress tolerance. As al‐
ready mentioned in the prior section, increased activity of this lipase 
also elongates life in nematodes. Diacylglycerol lipase is known for 
its role in hydrolyzing diacylglycerol into 2‐arachidonoylglycerol and 
a free fatty acid. Thus, overexpression of DAGL would be predicted 
TA B L E  5   Functions of different lipid proteins that regulate organismal aging
Lipid protein Function
Acid sphingomyelinase Breaks down sphingomyelin into ceramide and phosphorylcholine
Apolipoprotein D Lipoprotein that transports lipids throughout the body
Ceramidase Hydrolyzes ceramide into sphingosine
Ceramide synthase Utilizes sphingoid base and acyl‐CoA substrates to catalyze the formation of ceramides
Diglyceride acyltransferase Utilizes the substrates diacylglycerol and acyl‐CoA to form triglycerides
Diacylglycerol lipase Hydrolyzes diacylglycerol into 2‐arachidonoylglycerol
Dihydroceramide desaturase Converts dihydroceramide into ceramide via the insertion of a 4,5‐trans‐double bond into the sphingolipid back‐
bone of dihydroceramide
Dodecenoyl‐CoA 
delta‐isomerase
Catalyzes the degradation of long‐chain fatty acids during beta‐oxidation
Fatty acid amide hydrolase Degrades endogenous signaling lipids in the fatty acid amide family, including N‐acylethanolamines
Fatty acid‐binding proteins Intracellular lipid chaperones
Fatty acid desaturase Creates a carbon–carbon double bond in a fatty acid by removing two hydrogen atoms
Fatty acid elongase Extends the carbon chain length of a fatty acid
Glucosylceramide synthase Transfers glucose to a ceramide
Low‐density lipoprotein‐re‐
ceptor‐related protein
Cell‐surface endocytic receptor that binds extracellular ligands and targets them for intracellular degradation
Lysosomal lipase Hydrolase that breaks down fats (e.g., cholesterol and triglycerides) within the lysosome
Phospholipase A2 receptor Transmembrane protein that can bind to secreted phospholipase A2
Serine palmitoyltransferase Condenses palmitoyl CoA and serine to form 3‐ketodihydrosphingosine
VIT/vitellogenin Yolk lipoprotein that delivers cholesterol to oocytes
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to shunt more diacylglycerol into 2‐arachidonoylglycerol (Lin et al., 
2014). Drosophila lifespan is additionally extended by the overexpres‐
sion of fatty‐acid‐β‐oxidation‐related gene fatty acid‐binding protein 
or dodecenoyl‐CoA delta‐isomerase. This life extension is accompa‐
nied by an enhanced tolerance to oxidative stress and starvation. 
Fatty acid‐binding proteins function as intracellular lipid chaperones, 
while dodecenoyl‐CoA delta‐isomerase works to catalyze the degra‐
dation of long‐chain fatty acids during beta‐oxidation (Lee, Lee, Paik, 
& Min, 2012). Overexpression of human apolipoprotein D (ApoD), a 
lipid‐binding protein that promotes resistance to oxidative stress, is 
sufficient to enhance longevity and reduce age‐associated lipid per‐
oxide accumulation in Drosophila. These transgenic flies also enjoyed 
heightened protection against hyperoxia, dietary paraquat, and heat 
stress (Muffat, Walker, & Benzer, 2008). Transgenic overexpression 
of the fly homolog of ApoD, GLaz, analogously extends lifespan. Flies 
overexpressing GLaz exhibit an increased resistance to hyperoxia as 
well as superior walking and climbing abilities following sublethal ex‐
posure to hyperoxia. Overexpression of GLaz did not significantly 
alter weight, protein content, or lipid content but it did make flies 
more resistant to starvation (Walker, Muffat, Rundel, & Benzer, 
2006). The more indirect, transgenic overexpression of the histone 
deacetylase Sir2 in the adult fat body is another route to enhanced 
longevity and transcriptional profiling suggests that this gene affects 
lipid droplet biology (Hoffmann, Romey, Fink, Yong, & Roeder, 2013).
2.3 | Mosquitoes
Although the intervention is less direct, one study has found that a 
lipid‐related genetic intervention can prolong life in two different 
species of mosquitoes (Table 3). The laboratory of Michael Riehle 
has shown that the transgenic overexpression of the kinase Akt1 
exclusively in the fat body can increase survivorship in both Aedes 
aegypti and Anopheles stephensi mosquitoes (Arik et al., 2015). Akt1 
is a member of the canonical insulin/IGF signaling pathway, and its 
overexpression in A. aegypti or A. stephensi mosquito species was 
sufficient to increase survivorship by 14%–47% or 15%–45%, re‐
spectively. Elevated expression of this protein kinase also activated 
the downstream signaling molecules forkhead box O and p70 S6 ki‐
nase. Survivorship differences compared to controls were only ob‐
served when mosquitoes were fed blood and were abrogated when 
mosquitoes were fed only sugar. Interestingly, transgenic mosqui‐
toes also showed increased expression of the fat body vitellogenin, 
which is a precursor protein to egg yolk (Arik et al., 2015). The lack 
of a trade‐off between reproduction and longevity as well as the 
enhancement of a reproductive protein tied to prolonged life is 
noteworthy.
Although the invertebrate fat body combines many of the func‐
tions of adipose tissue and liver in vertebrates (Law & Wells, 1989), 
it is important to note that there are important differences between 
this organ and adipose fat in more complex animals. While vertebrate 
fat is known to promote unhealthy inflammation and produce pro‐
inflammatory cytokines, such deleterious effects have not yet been 
reported in the insect fat body (Azeez, Meintjes, & Chamunorwa, 
2014). Thus, lipid‐related longevity findings unique to the insect fat 
body may not reliably translate to vertebrate species and should be 
interpreted carefully.
2.4 | Rodents
While not as numerous as the lifespan data in simple organisms 
(Tables	1‒3),	different	interventions	linked	to	lipid	metabolism	have	
been shown to augment longevity in rodents (Table 4). In rats, the 
laboratory of Nir Barzilai has shown that surgical removal of visceral 
fat at 5 months of age significantly increases both mean and maxi‐
mum lifespan. It also reduces the incidence of severe renal disease 
(Muzumdar et al., 2008). Prior work from the same laboratory had 
shown that the removal of visceral fat improves insulin action and 
delays the onset of diabetes. Interestingly, the extraction of visceral 
fat did not alter levels of plasma free fatty acids. It did, however, 
decrease the expression of leptin and tumor necrosis factor‐alpha 
in subcutaneous adipose tissue (Gabriely et al., 2002). A third, ear‐
lier study from the same research group found that increased insulin 
sensitivity in response to visceral fat removal was accompanied by 
a marked decrease in the plasma levels of insulin‐like growth factor‐
binding protein‐1 (Barzilai et al., 1999).
We previously mentioned that, in Drosophila, overexpression 
of either human ApoD or GLaz, the fly homolog of human ApoD, 
is sufficient to extend lifespan (Muffat et al., 2008; Walker et al., 
2006). Suggestive of an evolutionarily conserved anti‐stress mech‐
anism, overexpression of human ApoD is also capable of increasing 
survival under conditions of oxidative stress in mice (Ganfornina 
et al., 2008). This overexpression also prevented the rise of brain 
lipid peroxides postoxidant treatment. In contrast, loss of function 
of this gene increased the level of brain lipid peroxidation, reduced 
protection against oxidative stress, and impaired both learning 
and locomotor abilities (Ganfornina et al., 2008). Separate work by 
Thomas and Yao showed that, compared to wild‐type mice, ApoD 
KO mice showed a significant increase in saturated fatty acids (16:0 
and 18:0), a monoene (16:1), dienes (linoleic acid and eicosadienoic 
acid), and a hexane (docosatetraenoic acid) (Thomas & Yao, 2007). 
Further suggestive of an important role for this lipoprotein, elevating 
ApoD production via adenovirus‐mediated gene transfer can reduce 
plasma triglyceride levels, increase plasma lipoprotein lipase activity, 
and enhance the catabolism of triglyceride‐rich particles in mice. In 
db/db obese mice, plasma levels of ApoD are reduced (Perdomo et 
al., 2010).
Another path to life extension in mice involves the steroid 17‐α‐
estradiol. Dietary supplementation with 17‐α‐estradiol (4.8 ppm) 
did not significantly impact lifespan in females but resulted in a 
12% median lifespan increase in males (Harrison et al., 2014). The 
National Institute on Aging Interventions Testing Program has 
confirmed the lifespan effect of 17‐α‐estradiol at a higher dose 
(14.4 ppm), reporting that it reliably extends median lifespan in 
males, but not females. The median lifespan increase, pooled from 
data across different sites, was 19% (Strong et al., 2016). Recent 
follow‐up work found that, in late life, 17‐α‐estradiol‐treated mice 
     |  11 of 26JOHNSON aNd STOLZING
better maintain their body weight, and in males, this weight is as‐
sociated with larger muscle fibers and heavier skeletal muscles 
compared with untreated controls (Garratt et al., 2019). Males also 
exhibit improved rotarod capacity and grip strength at 25 months. 
These data suggest that this steroidal estrogen compound can at‐
tenuate age‐related sarcopenia. Castrated males do not respond to 
17‐α‐estradiol, indicating that gonadal hormones at least partially 
underlie the observed antiaging mechanisms. This same study re‐
ported that late‐life function could be improved even if treatment 
with 17‐α‐estradiol did not start until 16 months (Garratt et al., 
2019). Treatment with this steroid additionally alters the metabolic 
profile of plasma and liver in males, including raising the abundance 
of different amino acids in the liver. The second estrogenic ste‐
roid estriol‐3‐sulfate was also elevated in males. Once more, these 
changes are either reduced or inhibited by castration (Garratt et 
al., 2018).
Directly prolonging longevity by genetically modifying a lipid 
gene has been demonstrated in mice. This was accomplished by 
creating a deficiency in the triglyceride synthesis enzyme acyl‐
CoA:diacylglycerol acyltransferase 1 (DGAT1). Female mice defi‐
cient in DGAT1 enjoyed increased mean and maximal lifespans as 
well as protection from age‐related increases in tissue triglycerides, 
body fat, and inflammation in white adipose tissue. Fecundity was 
decreased, and there were reductions in the levels of circulating in‐
sulin growth factor 1 and total cholesterol (Streeper et al., 2012). 
Prior work in these Dgat1−/− mice had shown that, although these 
transgenic animals can still synthesize triglycerides, they are lean 
and exhibit a resistance to diet‐induced obesity. Compared to 
controls, they displayed an increase in both energy expenditure 
and activity. Lactation was, however, defective in females (Smith 
et al., 2000). Despite being leaner, Dgat1−/− mice consumed more 
food at baseline and they had higher surface temperatures. When 
placed in a cold environment, their hyperphagia became more pro‐
nounced (Chen, Ladha, Smith, & Farese, 2003). Although a DGAT1 
deficiency recapitulates many aspects of caloric restriction—such as 
reduced adiposity, decreased tissue inflammation, and a lower fe‐
cundity—there are key differences. Not only do Dgat1−/− mice eat 
more than control mice, but there are key gene expression differ‐
ences. Streeper et al performed a whole‐genome microarray and 
pathway analyses on liver samples from calorie‐restricted mice and 
Dgat1−/− mice fed ad libitum. They found that, although caloric re‐
striction upregulates DGAT1 expression approximately twofold, 
approximately seven times as many genes were changed with ca‐
loric restriction versus mice with a DGAT1 deficiency. About 100 
genes were commonly upregulated or downregulated, however, and 
these included genes involved in immune responses, inflammation, 
and the cholesterol biosynthesis pathway (Streeper et al., 2012). Of 
note, livers from both Snell dwarf (Pit1dw/dwJ) and ribosomal protein 
S6 kinase 1 knockout mice (S6K1−/−) have similarly been reported to 
exhibit a decrease in cholesterol biosynthesis genes (Boylston et al., 
2004; Selman et al., 2009).
Another genetic intervention worth mentioning is the knock‐
down of the phospholipase A2 receptor (PLA2R1) in a mouse 
model of progeria (Griveau et al., 2018). Pla2r1 encodes for a trans‐
membrane protein receptor that binds to secreted phospholipase 
A2 proteins and regulates various cell signaling processes (Bernard 
& Vindrieux, 2014; Sukocheva et al., 2019). In progeria mice with 
premature aging, knockdown of Pla2r1 significantly decreases sev‐
eral different aging phenotypes. Specifically, Pla2r1‐deficient mice 
exhibited an improvement in grip strength, an increase in bone 
mineral content, and a reduction in the number of rib fractures. 
Trabecular separation in vertebral bone was also decreased. The 
inflammatory marker IL‐8 and the senescence marker p21 were 
both reduced in bone mRNA in mice lacking Pla2r1 compared with 
control progeria mice. Although maximal lifespan was increased in 
animals with a PLA2R1 deficiency, the difference in survival did 
not reach statistical significance compared with controls (Griveau 
et al., 2018).
While less direct, four other lipid‐related genetic approaches 
have been reported to extend mouse lifespan. These interven‐
tions either make an adipose‐specific genetic modification and/
or significantly impact lipid metabolism. The earliest of these 
studies enhanced longevity by specifically knocking out the in‐
sulin receptor in just adipose tissue. Fat‐specific insulin receptor 
knockout (FIRKO) mice have a normal food intake and show in‐
creases in mean, median, and maximum lifespans in both males 
and females. Moreover, their fat mass is reduced and they enjoy 
protection against age‐related obesity (Bluher, Kahn, & Kahn, 
2003). Follow‐up research discovered that FIRKO mice have an 
increased basal metabolic rate and a higher respiratory exchange 
ratio. They also show persistently elevated expression of mito‐
chondrial genes involved in glycolysis, tricarboxylic acid cycle, 
beta‐oxidation, and oxidative phosphorylation in white adipose 
tissue from mice aged six to 36 months. In contrast to the FIRKO 
mouse, expression of these mitochondrial genes tended to de‐
cline with age in controls (Katic et al., 2007). Mice harboring addi‐
tional genomic copies of the phosphatase Pten, another member 
of the canonical insulin signaling pathway, also live significantly 
longer. They have a lower cancer incidence and expend more en‐
ergy than controls. Their brown adipose tissue is hyperactive and 
also has higher levels of the uncoupling protein Ucp1, which the 
authors show is a downstream target of the transcription factor 
Foxo1. These transgenic mice additionally present with reduced 
adiposity as well as protection from insulin resistance and steato‐
sis (Ortega‐Molina et al., 2012).
Outside of the insulin signaling pathway, two additional indirect 
genetic alterations that are relevant to lipids have increased mouse 
lifespan. The uncoupling protein genes UCP2 and UCP3 were up‐
regulated, and lifespan was extended in mice lacking the ubiquitin‐
like gene FAT10 (Canaan et al., 2014). These FAT10‐deficient mice 
showed a preferential use of fat as fuel, a higher metabolic rate, less 
triglyceride content, a markedly reduced adiposity, and decreased 
weight gain. Enhanced insulin sensitivity was observed in metabolic 
tissues, and both circulating glucose and insulin levels were reduced. 
In addition to elevated uncoupling, they also exhibited increased 
AMPK activity and β‐oxidation (Canaan et al., 2014). Renal tubular 
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epithelial cells from FAT10−/− mice display abrogated activation of 
TNF‐α‐induced NF‐κB and a concomitantly reduced induction of 
NF‐κB‐regulated genes (Gong et al., 2010). Common types of chronic 
kidney disease are associated with the upregulation of FAT10 in hu‐
mans (Gong et al., 2010), and FAT10 gene expression was reported 
to be upregulated in the tumors of 90% of patients with hepatocel‐
lular carcinoma. The FAT10 gene is also upregulated in gastrointesti‐
nal and gynecological cancers (Lee et al., 2003). These data suggest 
that the upregulation of FAT10 promotes disease, while a deficiency 
in FAT10 delays aging and improves healthspan. A separate indirect 
genetic approach increased levels of the pro‐longevity metabolite 
NAD+ by overexpressing nicotinamide phosphoribosyltransferase 
in adipose tissue. This intervention extended the median lifespan 
and delayed age‐associated mortality in female mice. Healthspan 
was also increased, as evinced by observations of improved physi‐
cal activity, better sleep quality, higher glucose tolerance, superior 
glucose‐stimulated insulin secretion, and enhanced photoreceptor 
function (Yoshida et al., 2019).
A nongenetic, pro‐longevity dietary intervention is the ketogenic 
diet, which is an extreme form of a low‐carbohydrate diet. Recent 
work by Roberts et al. (2017) has shown that, when mice are fed 
isocaloric amounts of either a ketogenic diet (89% kcal from fat), a 
low‐carbohydrate diet (70% kcal from fat), or a control diet (65% 
kcal from carbohydrate), male mice in the ketogenic group showed a 
median, but not a maximum, increase in lifespan. The ketogenic diet 
was found to further decrease tumor incidence at the time of death 
and to preserve muscle mass, memory, and motor function in aged 
mice. Mice fed a low‐carbohydrate diet were the heaviest and had 
significantly more fat mass compared with mice fed either ketogenic 
or control diets. Blood ketones were elevated in the ketogenic diet 
group, and the concentration of free fatty acids was highest in the 
low‐carbohydrate diet group. Under a ketogenic diet regime, levels of 
phosphorylated and total acetyl‐CoA carboxylase were decreased, 
while levels of carnitine palmitoyltransferase 2 and medium‐chain 
acyl‐CoA dehydrogenase were increased. Total and phosphorylated 
pyruvate dehydrogenase protein levels were also increased in re‐
sponse to both low carbohydrate and ketogenic diets. Expression 
levels of the insulin/IGF and mammalian TOR (mTOR) pathways were 
also uniquely affected by a ketogenic diet (Roberts et al., 2017). 
Separate work by Newman et al have shown that a cyclical, isopro‐
tein ketogenic diet reduces midlife mortality and preserves memory 
performance with age in male mice (Newman et al., 2017).
3  | LIPID ‐REL ATED AGING MECHANISMS
These	 collated	 lifespan	 and	 healthspan	 data	 (Tables	 1‒4)	 make	 a	
lucid argument for a significant role of lipid metabolism in aging and 
lifespan regulation. When analyzing the published data in worms, 
flies, and rodents, some interesting trends begin to emerge. In this 
section, we discuss the aging mechanisms revealed to us from these 
lifespan studies and expand upon them.
3.1 | Fatty acids
Four different studies have shown that feeding with PUFAs or MFAs 
can enhance longevity in nematodes (Table 1). The compound α‐
lipoic acid, which is derived from the saturated fatty acid octanoic 
acid, can similarly extend lifespan in C. elegans and D. melanogaster 
(Tables 1 and 3), while fish oil containing eicosapentaenoic acid and 
docosahexaenoic acid can prolong life in C. elegans (Table 1). Thus, 
treatment with specific fatty acids is capable of modulating longev‐
ity. It would be invaluable to learn whether similar treatments can 
prolong life in more complex animal models, including vertebrates. 
Suggestive of the ability of fatty acids to impact important param‐
eters in mice, research by Nehra et al. (2012) have shown that the 
lifelong consumption of an ω‐3 fatty acid‐rich diet can prolong mu‐
rine reproduction function, while an ω‐6 fatty acid‐rich diet is associ‐
ated with poor reproductive success. Further studies are warranted 
to understand why different fatty acids exert different effects and 
to uncover what mechanisms each fatty acid utilizes. Unsaturated 
fatty acids have been reported to induce noncanonical autophagy 
(Niso‐Santano et al., 2015), which may be one mechanism by which 
fatty acids impact aging.
While direct feeding with fatty acids is sufficient to enhance lon‐
gevity, overexpression of fatty acid proteins (e.g., fatty acid amide 
hydrolase or the fatty acid desaturase FAT‐7 in worms and fatty 
acid‐binding protein or dodecenoyl‐CoA delta‐isomerase in flies) 
can also yield desirable aging effects (Tables 2 and 3). Conversely, 
the disruption of fatty acid genes can induce physiological harm. 
For example, mutant worms with severe PUFA deficiencies harbor 
neurological and growth defects (Watts & Browse, 2002). A role for 
fatty acids in regulating aging is further highlighted by important 
work by Shmookler Reis et al. (2011). By analyzing fatty acid pro‐
files across a panel of nematode mutants spanning a tenfold range 
of longevities, it was discovered that both fatty acid chain length 
and susceptibility to oxidation were substantially decreased in the 
longest‐lived mutants (Shmookler Reis et al., 2011). The authors 
proposed a functional model by which fatty acid chain length was 
reduced to maintain membrane fluidity given a reduction in lipid per‐
oxidation substrates. Eicosapentaenoic acid, the longest chain PUFA 
the authors observed in their study, had a profoundly negative lifes‐
pan effect when fed to C. elegans worms. While the shorter‐chain 
saturated fatty acid palmitic acid also reduced lifespan, it had a less 
dramatic effect compared with the longer‐chain eicosapentaenoic 
acid (Shmookler Reis et al., 2011). These results are corroborated 
by findings by Jové et al, which reported an inverse correlation 
between a mammal's lifespan and its concentration of long‐chain 
free fatty acids. Longer‐lived mammals had less plasma long‐chain 
free fatty acids, and conversely, shorter‐lived mammals had more 
plasma long‐chain free fatty acids. Mammals with greater lifespans 
also showed a lower peroxidizability index and less lipid peroxida‐
tion‐derived product content (Jove et al., 2013). In general, a higher 
MUFA:PUFA ratio is thought to be less susceptible to oxidation and 
is also associated with longevity (Schroeder & Brunet, 2015).
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Several other studies have coupled fatty acids to aging. In nu‐
trient‐poor environments or under conditions of oxidative stress, 
C. elegans mobilize lipids from the soma to the germline to support 
fecundity at the cost of survival. This trade‐off is coupled to the 
activation of the cytoprotective transcription factor SKN‐1 (Lynn et 
al., 2015). Although the effects of resveratrol are not consistently 
observed between different organisms, the improved health and 
survival of mice fed resveratrol while on a high‐fat diet is linked to 
the decreased expression of fatty acid synthase and the phosphor‐
ylation of acetyl‐CoA carboxylase (Baur et al., 2006). The dietary 
fat source utilized during dietary restriction can also significantly 
impact mouse lifespan. Calorically restricted mice fed a diet with 
lard lived longer than those on a diet supplemented with either fish 
or soybean oil. Lard is high in both saturated and monounsaturated 
fatty acids, while soybean oil and fish oil are high in ω‐6 and ω‐3 
PUFAs, respectively (Lopez‐Dominguez et al., 2015). Although fish 
oil (rich in ω‐3 PUFAs) does not extend lifespan in mice and has not 
been shown to enhance longevity or decrease mortality in humans 
(Aung et al., 2018; de Magalhaes, Muller, Rainger, & Steegenga, 
2016), ω‐3 PUFAs are associated with protection of the brain during 
aging (Denis, Potier, Heberden, & Vancassel, 2015; Derbyshire, 
2018) as well as cardiovascular risk protection (Innes & Calder, 2018) 
and improved clinical outcomes for rheumatic diseases (Akbar, Yang, 
Kurian, & Mohan, 2017). Certain ω‐6 PUFAs have also been linked to 
better health outcomes in humans. A meta‐analysis of randomized 
placebo‐controlled clinical trials revealed that the consumption of 
supplements containing eicosapentaenoic acid and docosahexae‐
noic acid was associated with lipid‐lowering, hypotensive, anti‐ar‐
rhythmic, and anti‐inflammatory action (AbuMweis, Jew, Tayyem, 
& Agraib, 2018).
Multiple myeloma has also been linked to fatty acid metabolism. 
It has been proposed that bone marrow adipocytes support the 
growth and evolution of cancer cells by providing them with free 
fatty acids (Masarwi, DeSchiffart, Ham, & Reagan, 2019). Relevantly, 
it was recently shown that the inhibition of fatty acid transport pro‐
tein 2 blocks tumor progression in mice and that this protein is up‐
regulated in polymorphonuclear myeloid‐derived suppressor cells, 
which are pathologically activated neutrophils that contribute to the 
failure of cancer therapies. The pathological activity of these cells 
involves the uptake of arachidonic acid and the synthesis of prosta‐
glandin E2 (Veglia et al., 2019).
3.2 | Lipases, lipoproteins, and cholesterol
Studies in nematodes and fruit flies have shown that the duration 
of life can be extended by overexpressing a lipase enzyme (Tables 
2 and 3). Moreover, life extension via increased lysosomal lipase ac‐
tivity has been linked to the antiaging, repair‐associated process of 
autophagy (Lapierre et al., 2012).
Lipases catalyze the hydrolysis of fats and work to process 
lipids such as triglycerides and cholesterol. The enzymatic activ‐
ity and mRNA levels of pancreatic lipase are decreased in older 
mice, and concomitantly, elderly mice exhibit decreased lipid ab‐
sorption (Yamamoto et al., 2014). Lipoprotein lipase activity has 
analogously been reported to decrease with age in rat postural 
skeletal muscle (Bey, Areiqat, Sano, & Hamilton, 2001), and during 
physical inactivity, activity of this same lipase is suppressed (Bey 
& Hamilton, 2003). Inactivity also caused a local reduction in the 
uptake of plasma triglyceride into muscle as well as a decrease 
in the concentration of high‐density lipoprotein (HDL) choles‐
terol. Treadmill walking raised lipoprotein lipase activity ~eight‐
fold (Bey & Hamilton, 2003). Lipoprotein lipase hydrolyzes the 
triacylglycerol component of lipoproteins, which transport fat 
molecules throughout the body. Aberrant lipoprotein lipase func‐
tion is associated with obesity, Alzheimer's disease, infection, 
insulin resistance, dyslipidemia associated with diabetes, chylo‐
micronemia, and atherosclerosis (Mead, Irvine, & Ramji, 2002). 
Monoacylglycerol lipase is highly expressed in primary tumors 
and promotes cancer pathogenesis via regulation of a fatty acid 
network (Nomura et al., 2010). These data suggest that, broadly, 
altering the activity of specific fat lipases may delay aging and 
symptoms of age‐related disease. It would be invaluable to know 
whether or not overexpressing a lipase could extend lifespan in 
mice or other vertebrate models.
Lipoproteins also have an important role to play in aging. Not 
only does inhibition of the yolk lipoprotein VIT/vitellogenin pro‐
long life in worms (Table 2), but the overexpression of the lipo‐
protein ApoD enhances survival and promotes stress resistance in 
flies and mice (Tables 3 and 4). In dogs, the expression of the apo‐B, 
E lipoprotein receptors declines linearly with increasing age. These 
receptors are capable of binding both the apo‐B‐containing low‐
density lipoproteins (LDLs) as well as the apo‐E‐containing choles‐
terol‐induced HDLs (Mahley, Hui, Innerarity, & Weisgraber, 1981). 
In rats, plasma cholesterol levels increase with age. This increase 
can be attenuated by treatment with growth hormone, and this at‐
tenuation was presumed to occur via effects on lipoprotein metab‐
olism (Parini, Angelin, & Rudling, 1999). Old mice show an impaired 
lipid mobilization response to fasting that includes milder fasting‐
induced changes in apolipoprotein gene expression compared with 
young mice (Araki, Okazaki, & Goto, 2004). Lipoproteins have also 
been correlated with various age‐related ailments. For example, 
human serum concentrations of lipoprotein(a) are significantly 
associated with an increased risk of Alzheimer's disease (Solfrizzi 
et al., 2002) and HDL cholesterol tends to be inversely associ‐
ated with cancer risk (Pirro et al., 2018). HDL cholesterol and tri‐
glycerides have been positively and negatively associated with an 
increased risk of age‐related macular degeneration, respectively 
(Colijn et al., 2019). HDL cholesterol is also a predictor of major 
cardiovascular events in patients treated with statins (Barter et 
al., 2007). Moreover, interventions that promote positive health 
outcomes are linked to LDL and cholesterol. Mice treated with the 
drug metformin, for example, enjoy an extended healthspan and 
lifespan as well as reduced LDL and cholesterol levels (Martin‐
Montalvo et al., 2013).
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3.3 | Triglycerides
One of the lipid‐related, lifespan‐increasing interventions in mice 
targeted triglyceride synthesis by creating a deficiency in the triglyc‐
eride synthesis enzyme acyl‐CoA:diacylglycerol acyltransferase 1 
(Table 4). Relatedly, long‐lived mice lacking the ubiquitin‐like FAT10 
gene displayed decreased triglyceride content (Canaan et al., 2014) 
and an adenovirus‐mediated increase in ApoD, a longevity‐relevant 
lipoprotein (Tables 3 and 4), reduces plasma triglyceride levels in 
mice (Perdomo et al., 2010). These data indicate that triglycerides 
are closely tied to the aging process. By compared metabolic param‐
eters in young and aged mice, Houtkooper et al have shown that 
aging is accompanied by decreased levels of plasma triglycerides 
and increased levels of free fatty acids (Houtkooper et al., 2011). 
The peptide hormone insulin, which is a well‐known regulator of 
aging, expands Drosophila fat cell mass by increasing the number 
of adipocytes and by promoting triglyceride storage (DiAngelo & 
Birnbaum, 2009). Linking triglycerides and lipases, the loss of adi‐
pose triglyceride lipase function is frequently observed in various 
types of human cancers. The loss of this lipase in a mouse model was 
found to induce the spontaneous development of pulmonary neo‐
plasia (Al‐Zoughbi et al., 2016). Mice deficient in senescence marker 
protein‐30, an androgen‐independent factor that dwindles with age, 
have shorter lifespans as well as higher levels of total hepatic triglyc‐
eride, total hepatic phospholipids, and cholesterol (Ishigami et al., 
2004). Adipocytes, which store triglycerides, have also been shown 
to promote metastatic initiation by sensitizing melanoma cells to the 
cytokine TGF‐β (Golan et al., 2019). These data make a strong case 
for triglycerides being highly relevant to aging and age‐related dis‐
ease. More specifically, a common theme appears to be that elevated 
levels of triglycerides are associated with physiological dysfunction.
3.4 | Ceramides and sphingolipids
Sphingolipids, including ceramides, have their own role to play in 
regulating	 aging	 (Tables	1‒3).	 In	nematodes,	 four	different	 studies	
were able to extend the lifespan of C. elegans by inhibiting sphin‐
golipid machinery (Table 2). These inhibited molecular targets 
include ceramide synthase genes, a sphingomyelinase, serine pal‐
mitoyltransferase, glucosylceramide synthase, dihydroceramide de‐
saturase, and neutral/acidic ceramidase (Table 2). In D. melanogaster, 
inactivation of the ceramidase enzyme Drosophila alkaline cerami‐
dase is sufficient to extend lifespan (Table 3). It is interesting that the 
impairment of sphingolipid/ceramide metabolism can prolong life in 
two different animal models. Data from rats show that sphingolipid 
catabolic enzyme activity increases during aging (Sacket, Chung, 
Okajima, & Im, 2009). Lifespan data from yeast further demonstrate 
that chronological lifespan can be elongated by reducing the rate 
of sphingolipid synthesis (Huang et al., 2014). Thus, disrupting the 
production of specific sphingolipids appears to exert pro‐longevity 
effects.
There are situations, however, where interfering with the sphin‐
golipid pathway can have detrimental health effects. Ceramide 
transfer protein is responsible for transferring ceramide from the 
endoplasmic reticulum to the Golgi complex. D. melanogaster flies 
functionally lacking this protein exhibit an increase in membrane flu‐
idity, reduced protection against oxidative damage, decreased ther‐
mal tolerance, and shortened lifespans (Rao et al., 2007). C. elegans 
worms that lack sphingosine kinase have decreased lifespans, smaller 
brood sizes, and reduced body sizes. They additionally show worse 
locomotor behavior and neuromuscular function in old age (Chan et 
al., 2017). It has also been suggested that defects in sphingolipid me‐
tabolism contribute to the pathogenesis of different brain disorders, 
including the age‐related neurodegenerative diseases Alzheimer's 
disease and Parkinson's disease (Di Pardo & Maglione, 2018). More 
data are required to understand why some sphingolipid‐targeted in‐
terventions are pro‐aging and why others are antiaging.
The ability of sphingolipids to influence aging matches up with 
their essential biological roles. The release of ceramide by acid 
sphingomyelinase, for example, is a prerequisite for CD95 signaling 
and apoptosis induction (Grassme et al., 2001). This is clinically sig‐
nificant as CD95 promotes tumor growth, and conversely, the loss 
of CD95 reduces both the incidence and size of tumors (Chen et al., 
2010). More broadly, ceramides increase in concentration with age 
in mammals and have been linked to various age‐related ailments, 
including cancer, type 2 diabetes, neurodegeneration, immune dys‐
function, and cardiovascular disease. Ceramide accumulation is also 
correlated with increased insulin resistance and oxidative stress 
(Huang et al., 2014). Very recent work by Chaurasia et al. (2019) have 
shown that the deletion of dihydroceramide desaturase 1 improves 
insulin resistance and hepatic steatosis in mice. Mechanistically, cer‐
amide was revealed to promote the uptake and storage of lipids and 
to impair glucose utilization (Chaurasia et al., 2019). Thus, clinical 
therapies that reduce ceramide concentrations may delay or amelio‐
rate symptoms of aging in humans.
3.5 | Phospholipids
It is intriguing that, in a mouse model of progeria, deleting the phos‐
pholipase receptor PLA2R1 improved specific healthspan param‐
eters (Table 4). In the same study, knockdown of this receptor was 
shown to prevent senescence in human fibroblasts (Griveau et al., 
2018). PLA2R1 is associated with both cancer suppression (Bernard & 
Vindrieux, 2014) and idiopathic membranous nephropathy (Coenen et 
al., 2013). More broadly, PLA2R1 is thought to be a regulator of various 
biological processes, including pro‐inflammatory signaling, apoptosis, 
senescence, and autoimmunity (Sukocheva et al., 2019). Bowhead 
whales and naked mole rats, two animals characterized by exceptional 
longevity, both exhibit unique phospholipid profiles (Borchman et al., 
2017; Mitchell et al., 2007). The disruption of lipid hydrolases that reg‐
ulate phospholipid metabolism has also been shown to decrease lifes‐
pan in worms (Park et al., 2018), flies (Kinghorn et al., 2015; Kunduri et 
al., 2014), and mice (Shinzawa et al., 2008). Conversely, treatment with 
phosphatidylcholine prolongs life in C. elegans under conditions of oxi‐
dative stress (Kim et al., 2019). While it has yet to be shown that modu‐
lating phospholipid machinery can lead to a statistically significant 
     |  15 of 26JOHNSON aNd STOLZING
increase in vertebrate lifespan, these data all suggest that phospholip‐
ids are highly relevant to aging.
3.6 | Ketogenic diet
In the prior section, we discussed that treatment with the ketone 
body ß‐hydroxybutyrate extends lifespan and increases thermotoler‐
ance in C. elegans (Edwards et al., 2014), while a ketogenic diet pro‐
longs lifespan and healthspan in mice (Newman et al., 2017; Roberts 
et al., 2017). In worms, ß‐hydroxybutyrate has been proposed to 
extend life via two different antiaging pathways, the first of which 
would inhibit histone deacetylases and lead to increased DAF‐16/
FOXO activity. The second pathway involves the mitochondrial me‐
tabolism of ß‐hydroxybutyrate, which would increase the production 
of reactive oxygen species via increased citric acid cycle metabolism 
and electron transport chain activity. This would activate the SKN‐1/
Nrf2 antioxidant response pathway and promote longevity (Edwards, 
Copes, & Bradshaw, 2015). In the original lifespan study, markers of 
neurodegenerative disease were attenuated in response to treatment 
with ß‐hydroxybutyrate (Edwards et al., 2014). A more recent paper 
by Manzo et al. (2018) have shown that, in a Drosophila model of 
amyotrophic lateral sclerosis, a significant decrease and increase were 
observed in the levels of ß‐hydroxybutyrate and carnitine conjugated 
long‐chain fatty acids, respectively. Feeding flies either ß‐hydroxy‐
butyrate or medium‐chain fatty acids improved locomotor function 
(Manzo et al., 2018). These data indicate that this ketone body can 
exert neuroprotective effects in two different animal models.
The ketogenic diet has been described as a biochemical model 
of fasting and works by producing ketone bodies (e.g., β‐hydroxybu‐
tyrate, acetoacetate, and acetone) from fats when glycogen stores 
have been depleted in the liver. Ketone bodies are thought to affect 
neurons by inducing changes in metabolism, epigenetics, and sig‐
naling (Fedorovich, Voronina, & Waseem, 2018). Interestingly, two 
separate studies have shown that a ketogenic diet preserves mem‐
ory performance during aging in male mice (Newman et al., 2017; 
Roberts et al., 2017). Given these data and that a ketogenic diet has 
been used to treat human epilepsy for almost a century (Boison, 
2017), it seems reasonable to hypothesize that ketone bodies exert 
neuroprotective effects. Indeed, a recent case study found that a ke‐
togenic diet rescued cognition in a 71‐year‐old female patient with a 
dual diagnosis of mild Alzheimer's disease and metabolic syndrome. 
The patient was heterozygous for the epsilon 4 allele of ApoE (Morrill 
& Gibas, 2019). It would be interesting to see whether, rather than a 
ketogenic diet, treatment with specific ketone bodies is sufficient to 
improve healthspan parameters and exert neuroprotective effects in 
vertebrate animal models.
3.7 | Canonical aging biology pathways
Although the specific mechanisms by which lipid interven‐
tions affect lifespan are largely unknown, it is clear that 
different interventions exhibit disparate levels of overlap with ca‐
nonical aging pathways, such as dietary restriction. For example, 
ß‐hydroxybutyrate does not extend life under dietary restriction 
in C. elegans, suggesting that this ketone body is a dietary restric‐
tion mimetic (Edwards et al., 2015). Similarly, the royal jelly com‐
ponent 10‐hydroxy‐2‐decenoic acid does not elongate life in eat‐2 
C. elegans mutants, suggesting the mechanism of action for this 
fatty acid overlaps with dietary restriction (Honda et al., 2015). 
Treatment with N‐acylethanolamine eicosapentaenoyl ethan‐
olamide suppresses dietary restriction‐induced life extension in 
worms. Moreover, enhanced longevity in response to overexpres‐
sion of the fatty acid amide hydrolase faah‐1 requires the dietary 
restriction‐relevant Foxa transcription factor PHA‐4 (Lucanic et 
al., 2011). Expression levels of VIT lipoprotein and lysosomal li‐
pases are decreased and increased, respectively, in response to 
dietary restriction (Seah et al., 2016). Full life extension via dietary 
restriction also involves the expression of fatty‐acid‐β‐oxidation‐
related genes (Lee et al., 2012). Enhanced longevity in response 
to the loss of the two ceramide synthase genes hyl‐1 and lagr‐1 
requires the transcription factors PHA‐4/FOXA, DAF‐16/FOXO, 
and SKN‐1 (Mosbech et al., 2013). The life extension in response 
to surgical removal of visceral fat in ad libitum‐fed rats was sig‐
nificantly less than the life extension observed in rats that were 
calorically restricted. This suggests that caloric restriction works, 
at least in the part, by pathways that are distinct from those that 
are affected by the removal of visceral fat (Muzumdar et al., 2008). 
Although some overlap exists, the significantly different gene ex‐
pression profiles in calorically restricted mice versus Dgat−/− mice 
indicate that this is yet another longevity mechanism that is not 
identical to caloric restriction (Streeper et al., 2012).
A few of the lifespan‐promoting studies discussed in the prior 
section investigated how a given intervention interacted with 
the canonical insulin/IGF pathway. The laboratory of Cynthia 
Kenyon has shown that the absence of daf‐2 in nematodes leads 
to the downregulation of the yolk lipoprotein genes vit‐2 and vit‐5 
(Murphy et al., 2003). Separate research efforts have demon‐
strated that long‐lived age‐1 worms exhibit decreased transcript 
levels of the fatty acid elongase genes elo‐1, elo‐2, and elo‐5 as 
well as the fatty acid desaturase fat‐4 (Shmookler Reis et al., 
2011). The longevity effect reported in response to knockdown of 
ASM‐3 depended on the functions of the insulin signaling genes 
daf‐16/FOXO and daf‐18/PTEN. Double mutant animals with both 
an asm‐3 deficiency and an age‐1/PI 3‐kinase deficiency were even 
longer‐lived (Kim & Sun, 2012). Reduced daf‐2 activity upregulates 
the lysosomal lipase lipl‐4, and RNAi against lipl‐4 partially sup‐
presses the longevity of daf‐2 mutants (Wang et al., 2008). Life 
extension generated by the overexpression of fatty‐acid‐β‐oxida‐
tion‐related genes activates dFOXO signal (Lee et al., 2012), and 
RNAi knockdown of LRP‐1 and LRP‐2 decreases how much AKT is 
phosphorylated (Brankatschk et al., 2014). Similarly, phosphatidyl‐
choline treatment promotes the nuclear accumulation of DAF‐16 
(Kim et al., 2019). Conversely, the HYL‐2 ceramide synthase acts 
independently of DAF‐2 (Menuz et al., 2009) and 10‐hydroxy‐2‐
decenoic acid‐induced life extension in C. elegans is not dependent 
on DAF‐16 or DAF‐2 (Honda et al., 2015, 2011).
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The TOR and AMPK signaling pathways have also been impli‐
cated in lipid lifespan studies. For example, the royal jelly compo‐
nent 10‐hydroxy‐2‐decenoic acid failed to extend lifespan in already 
long‐lived daf‐15 mutants. Since daf‐15 is a target of TOR, the au‐
thors conclude that this fatty acid overlaps with the TOR signaling 
pathway (Honda et al., 2015). DAF‐15/raptor has, however, been 
reported to be a point of convergence for both the insulin/IGF and 
TOR signaling pathways (Jia, Chen, & Riddle, 2004). Overexpressing 
diacylglycerol lipase decreases the phosphorylation levels of S6 
kinase, a target of TOR, while creating a transgenic mutant of this 
protein elevates the phosphorylation levels of S6 kinase (Lin et al., 
2014). In a long‐lived TOR pathway mutant with a defect in the worm 
ortholog of S6 kinase, levels of the lipid eicosapentaenoyl ethanol‐
amide were decreased. Direct treatment of these worms with eicos‐
apentaenoyl ethanolamide suppressed their longevity phenotype, 
thereby implicating N‐acylethanolamines in their extended lifespan 
(Lucanic et al., 2011). Inhibition of TOR in C. elegans was also found 
to induce the expression of the lysosomal lipase lipl‐4 (Lapierre et 
al., 2011). In mice, mTORC1 signaling was regulated in a tissue‐de‐
pendent manner by a ketogenic diet (Roberts et al., 2017). Like TOR, 
AMPK is a metabolic sensor that regulates the synthesis, oxidation, 
and lipolysis of lipids (Wang, Liu, Zhai, Zhang, & Tian, 2018). In the 
mouse study which showed that FAT10 knockout mice live longer, 
the authors noted that these mice had increased AMPK activity in 
skeletal muscle (Canaan et al., 2014).
Future studies should investigate more closely how different 
pro‐longevity lipid interventions overlap with each other as well with 
the classical aging pathways of dietary restriction, insulin/IGF, TOR, 
and AMPK.
4  | LIPID BIOMARKERS OF AGING IN 
HUMANS
4.1 | Genetic lipid signatures correlated with 
extreme human longevity
Genome‐wide association studies have identified multiple ge‐
netic factors that are correlated with exceptional longevity. Given 
the ability of lipid‐related interventions to modulate lifespan and 
healthspan	 in	 model	 organisms	 (Tables	 1‒4),	 lipid‐related	 genes	
would be expected to be associated with longer lifespans in 
humans.
This is indeed the case. Work by Atzmon et al. (2006) have 
shown	 that,	 among	 centenarians,	 homozygosity	 for	 the	 −641C	
allele in the APOC3 promoter (rs2542052) is significantly higher 
compared with controls. This genotype was associated with lower 
serum levels of APOC3, a favorable pattern of lipoprotein levels 
and sizes, a lower prevalence of hypertension, and greater insulin 
sensitivity (Atzmon et al., 2006). A separate study involving 338 
centenarians implicated both ApoE and angiotensin‐converting 
enzyme in human aging. The epsilon 4 allele of ApoE was sig‐
nificantly less common in centenarians compared with controls. 
Conversely, the epsilon 2 allele of ApoE was significantly more 
common in centenarians (Schachter et al., 1994). Ryu, Atzmon, 
Barzilai, Raghavachari, and Suh (2016) have shown that the ε3/ε4 
ApoE genotype is markedly depleted in centenarians, while the ε2/
ε3 genotype is substantially enriched. The epsilon 4 allele of ApoE 
is also a risk variant for late‐onset neurodegenerative diseases 
and is thought to contribute to the pathogenesis of Alzheimer's 
disease via multiple different pathways (Yamazaki, Painter, Bu, & 
Kanekiyo, 2016). Given that overexpression of human ApoD or 
GLaz, the fly homolog of ApoD, was shown to confer antiaging 
benefits in flies and mice (Tables 3 and 4), it is interesting that apo‐
lipoproteins are also associated with greater human longevity. This 
suggests that the protective effects of apolipoproteins are highly 
evolutionarily conserved and that clinical interventions targeting 
apolipoproteins could improve human healthspan.
In addition to ApoE, the PON1 gene encoding paraoxonase/
arylesterase 1 is reportedly associated with human longevity 
and is thought to impact lipid metabolism (Lescai, Marchegiani, & 
Franceschi, 2009). Tindale et al compared a group of healthy indi‐
viduals aged 85 or over to random midlife controls and identified 
that both the ε4 ApoE allele and the haptoglobin HP2 allele were 
less common among the healthy, aged group. Moreover, a network 
analysis of candidate longevity genes revealed that lipid and choles‐
terol metabolism was a common theme. Although it did not reach 
statistical significance (p = .052), the lipoprotein A gene LPA showed 
an interaction with the insulin signaling‐relevant FOXO3 (Tindale, 
Leach, Spinelli, & Brooks‐Wilson, 2017). A separate study also iden‐
tified lipoprotein A as being longevity‐associated (Joshi et al., 2017). 
Rs7844965, located in an intron of the lipid hydrolase EPHX2, was 
linked with increased human lifespan in a group of UK Biobank par‐
ticipants (Pilling et al., 2017). Genome‐wide association of 1 million 
parental lifespans has shown that gene pathways involving lipid 
proteins and homeostasis, synaptic function, and vesicle‐mediated 
transport are enriched for lifespan variation (Timmers et al., 2019). 
In addition, a group of Ashkenazi Jews with exceptional longevity 
(mean age of 98.2 years) and their offspring were reported to have 
an increased frequency of homozygosity for the codon 405 valine 
allele of the gene CETP, which encodes for cholesteryl ester transfer 
protein (Barzilai et al., 2003).
4.2 | Lipidomic analyses of extreme 
human longevity
A few studies have done broad, lipidomic analysis to assess the rela‐
tionship between aging and a large array of different lipids. For exam‐
ple, measurements of 128 lipid species using liquid chromatography 
coupled to mass spectrometry previously identified 19 lipid species 
associated with familial longevity in women. The authors compared 
the plasma lipidome of offspring of nonagenarians (a person between 
90 and 99 years) to non‐nonagenarian controls. Although no signifi‐
cant differences were observed for men, female offspring exhibited 
increased levels of either sphingomyelin or phosphocholine species as 
well as lower levels of long‐chain triglycerides and phosphoethanola‐
mine. Longevity was also associated with a higher ratio of MUFAs over 
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PUFAs (Gonzalez‐Covarrubias et al., 2013). Interestingly, many long‐
lived organisms or mutants have a decreased ratio of PUFA to MUFA 
(Papsdorf & Brunet, 2019). Separate work utilizing NMR metabonom‐
ics and shot‐gun lipidomics found that centenarians display unique 
changes in biosynthesis compared with elderly controls. In particular, 
phospholipids and sphingolipids were identified as putative markers 
and modulators of healthy aging (Montoliu et al., 2014). Recent lipid‐
omic work by Jové et al. have reported that a fatty acid profile resist‐
ant to lipid peroxidation is associated with extreme longevity. Extreme 
longevity was associated with a higher saturated fatty acid content 
as well as a lower content of unsaturated fatty acids, such as PUFAs. 
Longer lifespans were also correlated with a higher average fatty acid 
chain length. The authors also proposed that specific lipid species of 
ceramides are biomarkers of extreme longevity (Jove et al., 2017). Even 
more recently, Wong et al have used lipidomics to discover that their 
“oldest old” subjects over 95 years of age exhibited globally low levels 
of lipids. Women and men also showed sex‐related age differences in 
their plasma lipid levels. For example, women had higher levels of LDL 
cholesterol, HDL cholesterol, and total cholesterol. Sphingomyelin and 
docosahexaenoic acid‐containing phospholipid levels were also higher 
in females (Wong et al., 2019).
Although more studies and data are required to better understand 
how the lipidome changes with age, these few studies harbor shared 
findings. Two different lipidomic screens reported that sphingomy‐
elin levels increase with age for women (Gonzalez‐Covarrubias et al., 
2013; Wong et al., 2019). Two of these papers reported that human 
longevity is associated with lower unsaturated fatty acid content 
(Gonzalez‐Covarrubias et al., 2013; Jove et al., 2017) and two dif‐
ferent studies identified sex‐specific age differences in lipid content 
(Gonzalez‐Covarrubias et al., 2013; Wong et al., 2019). All three studies 
linked sphingolipids to aging (Gonzalez‐Covarrubias et al., 2013; Jove 
et al., 2017; Wong et al., 2019). Broader lipidomic screens are war‐
ranted to better understand additional plasma lipids that with age and 
how plasma lipids uniquely change for men and women.
4.3 | Triglycerides as blood biomarkers of aging
Other nonlipidomic studies have analyzed whether or not a sin‐
gle lipid or few different lipids are useful as biomarkers of aging 
or age‐related disease. Multiple papers have identified plasma 
triglycerides, the lipids stored in fat cells that make up most of 
body fat, as a potential blood aging biomarker. For example, 
Parthasarathy et al have reported that triglycerides levels are in‐
versely correlated with cognitive function in nondemented elderly 
adults (Parthasarathy et al., 2017). Triglycerides have been re‐
ported to increase progressively with age and have been actively 
proposed as a biomarker of aging (Xia et al., 2017). Triglyceride 
levels increase in older patients and are thought to be a signifi‐
cant risk factor for coronary artery disease, particularly in women 
(LaRosa, 1997). These data suggest that triglycerides have the 
potential to be a useful lipid biomarker. However, it is important 
to note that genetically predicted triglyceride levels have been 
reported to be unassociated with either frailty and longevity in 
elderly populations (Liu et al., 2017). Ergo, while most studies 
indicate that triglycerides increase with age (Papsdorf & Brunet, 
2019), it remains to be determined whether or not triglyceride lev‐
els can accurately predict parameters of aging.
4.4 | Lipoproteins and cholesterol as blood 
biomarkers of aging
Given everything mentioned heretofore, it should be unsurpris‐
ing that ApoE plasma levels have been proposed as a human aging 
biomarker and have been reported to strongly associate with car‐
diovascular mortality (Mooijaart et al., 2006). The related LDL apoli‐
poprotein B and LDL cholesterol reportedly both increase with age, 
and these increases are linked to a progressively reduced fractional 
catabolic rate of LDL apolipoprotein B. Stimulation of hepatic LDL re‐
ceptor expression via the cholesterol‐lowering medication cholesty‐
ramine in six old males was sufficient to increase the catabolic rate 
to levels identified in younger subjects. These data indicate the LDL 
increase with age occurs due to a reduced capacity for its removal 
(Ericsson et al., 1991).
Several studies have examined how LDL and HDL change over 
time, and some of the results are conflictive. A systematic review 
by Wirth et al. (2017) assessed various markers of human seden‐
tary behavior in the elderly. They identified a positive correlation 
for LDL and ApoA1 as well as a negative correlation for HDL with 
older sedentary behavior (Wirth et al., 2017). Offspring of indi‐
viduals with exceptional longevity have significantly larger LDL 
and HDL particle sizes as well as a lower prevalence of cardio‐
vascular disease, hypertension, and metabolic syndrome (Barzilai 
et al., 2003). Ashkenazi Jewish offspring of centenarians showed 
fewer and larger LDL particles compared with their same‐aged 
partners. No differences in HDL particle phenotypes were re‐
ported (Heijmans et al., 2006). Larger LDL particle sizes as well as 
lower triglyceride levels were reported in offspring of nonagenar‐
ian siblings compared with controls, which were partners of the 
offspring. LDL particle size was associated with male longevity, 
while triglyceride levels were associated with female longevity 
(Vaarhorst et al., 2011). HDL from older subjects was reported to 
have an altered composition that impaired its antioxidant prop‐
erties and overall function. HDL from elderly patients contained 
less cholesterol and had more sphingomyelin (Holzer et al., 2013). 
Relatedly, a progressive decline in plasma HDL concentrations 
has been associated with cognitive dysfunction in centenarians 
(Atzmon et al., 2002).
Data also suggest that plasma cholesterol may be a viable human 
aging blood biomarker, though the data are disparate. Both female 
and male offspring of centenarians reportedly have higher plasma 
levels of HDL cholesterol compared with controls. Men also exhib‐
ited significantly lower LDL cholesterol levels (Barzilai, Gabriely, 
Gabriely, Iankowitz, & Sorkin, 2001). Work by Weijenberg, Feskens, 
and Kromhout (1996) found that total cholesterol decreased with 
age, but HDL cholesterol did not change significantly with age in 
Dutch men. Kreisberg and Kasim previously concluded that total 
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cholesterol, HDL cholesterol, and LDL cholesterol change uniquely 
over time for both men and women (Kreisberg & Kasim, 1987). A 
biomarker signature comprised of multiple different biomarkers, in‐
cluding total cholesterol, was found to be associated with lower mor‐
bidity and mortality as well as better physical function (Sebastiani et 
al., 2017). More comprehensive, systematic analyses are required to 
better understand the relationship between cholesterol and lipopro‐
teins with aging as well as how this relationship differs between men 
and women.
4.5 | Fatty acids and lipid peroxidation as blood 
biomarkers of aging
Fatty acids and lipid peroxidation have additionally been implicated 
as potential blood lipid biomarkers of human aging. Given that a 
higher dietary intake and higher circulating levels of eicosapentae‐
noic acid and docosahexaenoic acid have been associated with a 
reduced risk of dementia, Tan et al. analyzed red blood cell levels 
of these ω‐3 PUFAs in 1,575 dementia‐free patients. Participants 
with lower docosahexaenoic acid had lower scores on tests for vis‐
ual memory, abstract thinking, and executive function. Those with 
docosahexaenoic acid levels in the lowest quartile also had greater 
white matter hyperintensity and lower total brain volumes. The au‐
thors concluded that this PUFA was therefore a candidate marker of 
brain aging (Tan et al., 2012). By assessing different fatty acids with 
age, it was reported that plasma saturated, polyunsaturated, and 
monounsaturated fatty acids increase with age. Concomitant with 
this, circulating concentrations of IL‐6 and TNF‐α increased, while 
IL‐10 and TGF‐β1 decreased over time. Certain saturated fatty acids 
were reported to be associated with changing levels of TGF‐β1 and 
TNF‐α (Pararasa et al., 2016).
In normal elderly people, a decrease in antioxidants and an in‐
crease in lipid peroxidation were reported compared with younger 
controls. The lipid peroxidation malondialdehyde was highly elevated 
in older patients with diabetes and hypertension (Akila, Harishchandra, 
D'Souza, & D'Souza, 2007). Yavuzer et al. (2016) have shown that both 
hypertension and aging are associated with higher lipid peroxidation 
in humans. In particular, they identified lipid hydroperoxide and thio‐
barbituric acid‐reactive substances as sensitive markers for both hy‐
pertension and aging in elderly patients (Yavuzer et al., 2016). Aging is 
additionally associated with an increase in lipid peroxidation in cardiac 
muscle obtained from 59 patient donors (age range of 8–86 years) with 
a mean age of 56 ± 12 years (Miro et al., 2000).
4.6 | Sphingolipids and phospholipids as blood 
biomarkers of aging
Very little work has explicitly assessed whether or not sphingolipids, 
including ceramides, are candidate human aging blood biomarkers. 
Plasma sphingolipids have been proposed as biomarkers for Alzheimer's 
disease (Mielke & Haughey, 2012) and have also been linked to the age‐
related diseases of diabetes, obesity, nonalcoholic fatty liver disease, 
insulin resistance, and cardiovascular disease (Iqbal, Walsh, Hammad, 
& Hussain, 2017). The plasma ceramide C16:0 has been associated 
with a slower gait, an important aging marker of physical function 
(Wennberg et al., 2018). These data as well as the lipidomic data previ‐
ously mentioned (Gonzalez‐Covarrubias et al., 2013; Montoliu et al., 
2014; Wong et al., 2019) nicely justify further exploring the relation‐
ship between blood sphingolipids and human aging. Indeed, a recent 
study in nondiabetic patients found that higher levels of plasma insulin 
and an increased HOMA of insulin resistance score were associated 
with an elevation in plasma ceramides (Lemaitre et al., 2018).
With regard to phospholipids, low plasma levels of lysophospha‐
tidylcholines were found to be associated with impaired mitochon‐
drial oxidative capacity in adults (Semba et al., 2019). Lower levels 
of blood phospholipids, including the lysophosphatidylcholine 18:2, 
were separately shown to be highly predictive of memory impair‐
ment in older adults (Mapstone et al., 2014). Low plasma levels of 
lysophosphatidylcholine 18:2 also predict a greater decline of gait 
speed in the elderly (Gonzalez‐Freire et al., 2019). Patients with 
cancer, a classical age‐related disease, analogously show a decrease 
in the concentration of plasma lysophosphatidylcholine (Taylor, 
Arends, Hodina, Unger, & Massing, 2007). Given these data and that 
both phosphatidylcholine and phosphatidylethanolamine have been 
reported to decline with age in model organisms (Papsdorf & Brunet, 
2019), phospholipids show substantial potential as blood aging bio‐
markers in humans. Interestingly, a study by Trabado et al. (2017) 
have reported that elderly healthy subjects have higher plasma 
levels of sphingomyelins and phosphatidylcholines compared with 
young subjects. Although this reinforces the theory that these lipids 
are connected to aging, it suggests that specific lipids within these 
families may uniquely increase or decrease with age. It also suggests 
that other parameters, like patient health or genetic variability, may 
influence the relationship between a given sphingolipid or phospho‐
lipid with age.
5  | CONCLUDING REMARKS AND FUTURE 
DIREC TIONS
Although many questions remain to be elucidated, it is clear that 
lipid metabolism has an imperative role to play in regulating the 
aging process. Lipid‐related interventions are capable of modulating 
lifespan in various model organisms. Moreover, specific lipids and 
lipid‐related molecules have been shown to increase or decrease 
in an age‐dependent manner. Lastly, lipid‐related genetic markers 
can strongly correlate with exceptional longevity in humans. These 
qualities exceed the requirement for a hallmark of aging (Lopez‐Otin 
et al., 2013) and demonstrate unequivocally that lipid metabolism is 
intimately connected to the aging process. They additionally high‐
light several different potential pathways that could be targeted to 
increase human healthspan (Figure 2). Since many of our proposed 
target pathways (Figure 2) overlap with each other (e.g., lipase activ‐
ity and fatty acid metabolism), it would be intriguing to learn what 
aging mechanisms are shared between each of these targets when 
they impact longevity.
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Future work should aim to better understand the mechanisms 
that underlie lifespan changes in response to specific lipid‐related 
interventions in model organisms. Additional research in vertebrate 
models, such as African turquoise killifish, mice, rats, and Rhesus 
monkeys, is especially needed. Identifying unique lipid characteris‐
tics shared among animals with extreme longevity (e.g., Greenland 
shark, bowhead whale, giant tortoise, and ocean quahog clam) or 
theoretical immortality (e.g., planarian flatworms and hydra) would 
also help illuminate pro‐longevity lipid pathways. Another approach 
would be to do comprehensive analyses of healthspan parameters 
and the incidence of age‐related disease in patients being treated 
with lipid‐relevant pharmacological interventions or patients with 
lipid‐related genetic mutations. This would help to identify targets 
and treatments that could be explicitly utilized to elongate human 
healthspan.
We are also hopeful that lipid signatures could be developed 
as reliable biomarkers to accurately predict human biological age. 
Although they are usefully predictive, large human cohort studies 
represent a current bottleneck and it might be good to think about 
alternative study designs. If data sharing becomes more common, 
reanalyzing data may help to glean new insights from existing 
datasets. Another experimental approach could make use of the 
many apps that exist to trace daily food intake, composition, and 
activity. Recruiting people to document daily intake of specific 
food compounds could be coupled with various measurements to 
study lipids and aging or aging‐related health outcomes in large 
F I G U R E  2   Proposed lipid‐related pathways that could be targeted to extend human healthspan. The overexpression of lysosomal lipase 
enhances longevity in worms, while the overexpression of diacylglycerol lipase extends lifespan in both worms and flies. Gene inactivation 
or inhibition of genes encoding the sphingolipid‐relevant sphingomyelinase‐3, glucosylceramide synthase, serine palmitoyltransferase, 
dihydroceramide desaturase, neutral/acidic ceramidase, or ceramide synthase proteins extends life in Caenorhabditis elegans, while the 
inactivation of alkaline ceramidase increases lifespan in Drosophila melanogaster. Longevity can also be increased by feeding specific 
monounsaturated or polyunsaturated fatty acids to worms, by overexpressing fatty acid amide hydrolase in worms, or by overexpressing 
fatty acid‐binding protein or dodecenoyl‐CoA delta‐isomerase in flies. The overexpression of apolipoprotein D enhances survival in flies 
and mice, and the overexpression of the fly homolog of this gene extends lifespan in flies. In worms, RNAi knockdown against the yolk 
lipoprotein VIT/vitellogenin prolongs life. Survival time can also be elongated by RNAi knockdown against low‐density lipoprotein‐receptor‐
related protein 1 and low‐density lipoprotein‐receptor‐related protein 2 in Drosophila. Creating a deficiency in the triglyceride synthesis 
enzyme acyl‐CoA:diacylglycerol acyltransferase 1 boosts longevity in mice and knockdown of the phospholipase A2 receptor improves 
healthspan parameters in a mouse model of progeria. Relevant to the latter finding, treating worms with phosphatidylcholine boosts 
longevity. Treating C. elegans with the ketone body ß‐hydroxybutyrate or feeding mice with a ketogenic diet additionally extends lifespan. 
There are likely additional lipid‐related healthspan targets that remain to be elucidated
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human datasets. Given the current data, we are optimistic that 
certain lipid‐related interventions are capable of extending human 
healthspan.
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